BioRestorative Therapies, Inc. (BRTX): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.51M

As of 2025-12-31

$3.11M

As of 2026-03-31

-4.1%

3-year compound annual growth

2021-12-31 Cash & Equivalents (USD) 2025-12-31

Period ended	Cash & Equivalents	Change YoY	Source filing
2025-12-31	$1.51M	+175.8%	2026-03-26, Balance as of period end
2024-12-31	$547.9K	-38.0%	2026-03-26, Balance as of period end
2023-12-31	$884.4K	-48.4%	2025-03-28, Balance as of period end
2022-12-31	$1.71M	n/c	2024-06-11, Balance as of period end
2021-12-31	$21.03M	n/a	2023-03-27, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cash & Equivalents	Change YoY
BioRestorative Therapies, Inc. (BRTX)	2025-12-31	$1.51M	+175.8%
Mangoceuticals, Inc. (MGRX)	2025-12-31	$1.49M	n/m
Charming Medical Ltd (MCTA)	2026-03-31	$4.70M	+475.3%
Pacific Health Care Organization Inc (PFHO)	2025-12-31	$2.17M	+4.7%
Marpai, Inc. (MRAI)	2025-12-31	$133.0K	-82.6%
Cryo Cell International Inc (CCEL)	2025-11-30	$319.0K	-43.1%
Viemed Healthcare, Inc. (VMD)	2025-12-31	$13.50M	-23.0%
Sotera Health Co (SHC)	2025-12-31	$344.62M	+24.3%
Progyny, Inc. (PGNY)	2025-12-31	$112.24M	-30.9%

Compare BRTX, MGRX, MCTA, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗